11,309
Total Claims
$2.0M
Drug Cost
1,551
Beneficiaries
$1,286
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-16%
Cost per patient vs peers
$1,286 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,556 claims · $241K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 802 | $962K |
| Evolocumab | 254 | $264K |
| Rivaroxaban | 133 | $162K |
| Sacubitril/Valsartan | 86 | $123K |
| Ticagrelor | 48 | $44K |
| Empagliflozin | 37 | $38K |
| Alirocumab | 51 | $35K |
| Atorvastatin Calcium | 1,434 | $25K |
| Evolocumab | 16 | $23K |
| Valsartan | 607 | $21K |
| Ezetimibe | 566 | $20K |
| Semaglutide | 12 | $20K |
| Metoprolol Succinate | 734 | $19K |
| Ivabradine Hcl | 16 | $19K |
| Potassium Chloride | 386 | $15K |
Prescribing Profile
Patient Profile
75
Avg Age
53%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About